Abstract:4158 G-protein-coupled receptors (GPCRs) represent the largest protein family in the human genome, and are involved in many cellular processes such as migration, proliferation, and invasion. GPCRs induce biological effects through the association of their cytoplasmic domains with trimeric G proteins that activate multiple signaling cascades, leading to the activation of various transcription factors including NF-κB. NF-κB is a family of transcription factors that play a pivotal role in regulating gene expression of many cytokines and survival factors. However, the molecular mechanism by which GPCRs induce NF-κB activation has not been fully characterized. Here we demonstrate that CARMA3 (Caspase recruitment domain and membrane associated guanylate kinase domain-containing protein 3), a scaffold molecule, is essential for GPCR-induced NF-κB activation. Using a gene-targeting approach, we generated CARMA3-deficient mice. We found that CARMA3-deficient mice exhibit a neural tube closure defect with incomplete penetrance, similar to that of a CARMA3-binding partner, Bcl10 (B-cell lymphoma protein 10). Using CARMA3-deficient cells, we show that the GPCR-ligands LPA (lysophosphatidic acid), ET-1 (endothelin-1), and 5-HT (serotonin) all signal through CARMA3 to activate NF-κB. Furthermore, 12-phorbol-myristate-13-acetate (PMA) and ionomycin (Iono.), two synthetic protein kinase C (PKC) agonists, also fail to activate NF-κB in CARMA3-deficient cells. Finally, our results indicate that this NF-κB activation defect is not due to an absence of phosphorylation of the inhibitor of NF-κB kinases (IKK) α and β. Instead, this defect is likely due deficient ubiquitination of the NF-κB-essential modulator (NEMO). Thus, we have provided the first genetic evidence that CARMA3 plays an essential role downstream of GPCRs and PKC to regulate NEMO ubiquitination, ultimately leading to NF-κB activation.

CARMA1 Coiled-coil Domain is Involved in the Oligomerization and Subcellular Localization of CARMA1 and is Required for T Cell Receptor-induced NF-κB Activation*

CD3/CD28 Costimulation-Induced NF-κB Activation is Mediated by Recruitment of Protein Kinase C-θ, Bcl10, and IκB Kinase Β to the Immunological Synapse Through CARMA1

Phosphorylation of Carma1 Plays A Critical Role in T Cell Receptor-Mediated Nf-Kappa B Activation

CD3/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1.

A Requirement for CARMA1 in TCR-induced NF-κB Activation

The Molecular Adapter Carma1 Controls Entry of IκB Kinase into the Central Immune Synapse

CARMA1-mediated NF-kappaB and JNK Activation in Lymphocytes.

Carma3 Deficiency Abrogates G Protein-Coupled Receptor-Induced Nf-Kappa B Activation

Potential Role of Carma1 in Cd40-Induced Splenic B Cell Proliferation and Marginal Zone B Cell Maturation

CARMA3 Deficiency Abrogates G-protein-coupled Receptor Induced NF-κB Activation

CARMA3: Scaffold Protein Involved in NF-κB Signaling

MALT1/Paracaspase is a Signaling Component Downstream of CARMA1 and Mediates T Cell Receptor-induced NF-κB Activation

Carma1 Controls Th2 Cell-Specific Cytokine Expression Through Regulating Junb and Gata3 Transcription Factors

NF-κB Signaling Pathways Regulated by CARMA Family of Scaffold Proteins

Activation of the Transcription Factor C-Maf in T Cells is Dependent on the CARMA1-IKKβ Signaling Cascade

CARMA3 is Crucial for EGFR-Induced Activation of NF-κB and Tumor Progression

The Trk fused gene-product (Tfg) is part of a 600-700kDa CARMA1 complex

The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling.

CARMA3: A potential therapeutic target in non-cancer diseases

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Molecular Dynamics of Co-signal Molecules in T-Cell Activation